C. Payne
Financieel Directeur/CFO bij APTOSE BIOSCIENCES INC.
Vermogen: 8 505 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van C. Payne
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Extinct | Biotechnology | 12 | |
| Public Company | Pharmaceuticals: Major | 12 | |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA.
5
| Extinct | Medical Specialties | 5 |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA.
2
| Extinct | Medical Specialties | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met C. Payne via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Western Ontario | College/University | Corporate Officer/Principal Undergraduate Degree | |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Founder | |
| ACMP IV LLC | Director/Board Member | ||
MTIP AG
 MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Investment Managers | Private Equity Investor | |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
AOT AG
 AOT AG Medical SpecialtiesHealth Technology AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Panavance Therapeutics, Inc. | Director/Board Member | ||
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX. | College/University | Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Pharmaceuticals: Major | Director/Board Member | |
Verana Health, Inc.
 Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Paige.Ai, Inc.
 Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Canada | 3 |
| Zwitserland | 3 |
| Australië | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 206 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 53 |
| Chairman | 41 |
| Chief Executive Officer | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Augustine Lawlor | 43 |
| Asish Xavier | 33 |
| Erich Maximilian Platzer | 31 |
| Jeff Himawan | 24 |
| John P. Richard | 24 |
| Harold Selick | 24 |
| Bernd Seizinger | 23 |
| Errol de Souza | 21 |
| Sharon Tetlow | 21 |
| David Mack | 19 |
| Stephen Hill | 18 |
| Denis Burger | 16 |
| Nassim Usman | 15 |
| Warren Whitehead | 14 |
| Edward Williams | 13 |
